Can advanced heart scans predict the biggest killer in Friedreich's ataxia?

NCT ID NCT02316314

Recruiting now Knowledge-focused Sponsor: Weill Medical College of Cornell University Source: ClinicalTrials.gov ↗

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This study aims to better understand heart disease in people with Friedreich's ataxia, a genetic disorder that affects coordination and often leads to life-threatening cardiomyopathy. Researchers will use cardiac MRI, echocardiograms, and exercise stress tests to measure heart function and look for early signs of damage. The goal is to identify reliable markers of heart disease that could guide future treatments and monitoring.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better ways to detect and monitor heart disease in people with Friedreich's ataxia, potentially improving care.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly improve health. The findings may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FRIEDREICH'S ATAXIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Ataxia cardiomyopathy Friedreich ataxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FRIEDREICH'S ATAXIA

Contacts and locations

Locations

Weill Cornell Medicine
RECRUITING

New York, New York, 10021, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.